Agape ATP (ATPC) Competitors $1.29 -0.13 (-9.15%) Closing price 03:59 PM EasternExtended Trading$1.36 +0.08 (+5.81%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ATPC vs. VMD, XGN, DCGO, EUDA, SERA, CORBF, QIPT, NAKA, KDLY, and BMGLShould you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), KindlyMD (NAKA), Kindly MD (KDLY), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry. Agape ATP vs. Its Competitors Viemed Healthcare Exagen DocGo EUDA Health Sera Prognostics Global Cord Blood Quipt Home Medical KindlyMD Kindly MD Basel Medical Group Viemed Healthcare (NASDAQ:VMD) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment. Do insiders & institutionals have more ownership in VMD or ATPC? 74.2% of Viemed Healthcare shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by company insiders. Comparatively, 9.7% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is VMD or ATPC more profitable? Viemed Healthcare has a net margin of 5.28% compared to Agape ATP's net margin of -191.34%. Viemed Healthcare's return on equity of 9.49% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets Viemed Healthcare5.28% 9.49% 7.14% Agape ATP -191.34%-30.95%-27.00% Which has higher earnings & valuation, VMD or ATPC? Viemed Healthcare has higher revenue and earnings than Agape ATP. Agape ATP is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViemed Healthcare$224.26M1.14$11.27M$0.3021.63Agape ATP$1.32M48.87-$2.47M-$0.60-2.15 Does the media refer more to VMD or ATPC? In the previous week, Viemed Healthcare's average media sentiment score of 1.87 beat Agape ATP's score of 1.24 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Overall Sentiment Viemed Healthcare Very Positive Agape ATP Positive Which has more volatility and risk, VMD or ATPC? Viemed Healthcare has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.98, suggesting that its stock price is 198% less volatile than the S&P 500. SummaryViemed Healthcare beats Agape ATP on 11 of the 12 factors compared between the two stocks. Get Agape ATP News Delivered to You Automatically Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATPC vs. The Competition Export to ExcelMetricAgape ATPMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.01M$10.12B$5.52B$9.41BDividend YieldN/A2.05%3.80%4.04%P/E Ratio-2.1516.5928.0419.84Price / Sales48.8729.60429.5399.59Price / CashN/A22.2635.8457.94Price / Book2.693.578.125.65Net Income-$2.47M$235.43M$3.25B$258.00M7 Day Performance-13.31%-1.67%0.97%2.09%1 Month Performance-15.47%2.91%7.36%11.13%1 Year Performance-67.26%-16.44%31.31%18.40% Agape ATP Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATPCAgape ATP0.661 of 5 stars$1.29-9.2%N/A-64.5%$71.01M$1.32M-2.1540Positive NewsGap DownVMDViemed Healthcare1.814 of 5 stars$6.62-1.5%N/A-7.2%$265.60M$224.26M22.071,179Positive NewsXGNExagen3.1505 of 5 stars$6.78-4.1%$7.50+10.6%+250.2%$150.59M$55.64M-8.07220News CoverageDCGODocGo1.9038 of 5 stars$1.39-4.8%$3.56+156.1%-58.1%$148.90M$616.55M-69.504,407EUDAEUDA Health1.2769 of 5 stars$3.23-1.8%N/A-17.9%$122.24M$4.01M0.002News CoveragePositive NewsSERASera Prognostics0.4877 of 5 stars$2.70-2.2%N/A-62.4%$103.98M$80K-2.87120CORBFGlobal Cord BloodN/A$0.75flatN/A-37.5%$91.16M$196.12M0.001,200Gap DownQIPTQuipt Home Medical2.8317 of 5 stars$2.00+5.3%$2.85+42.5%-40.8%$82.54M$245.91M-9.521,200NAKAKindlyMDN/A$11.77-2.6%N/AN/A$72.90M$2.72M-15.29N/AGap UpKDLYKindly MDN/A$12.09-1.7%N/A+385.5%$72.81M$2.47M-15.70N/ANews CoverageBMGLBasel Medical GroupN/A$2.56-16.3%N/AN/A$56.47MN/A0.0036News Coverage Related Companies and Tools Related Companies VMD Competitors XGN Competitors DCGO Competitors EUDA Competitors SERA Competitors CORBF Competitors QIPT Competitors NAKA Competitors KDLY Competitors BMGL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATPC) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agape ATP Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Agape ATP With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
